Imaging test detects Alzheimer's disease that is likely to progress

Dec 15, 2009

Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's disease with dementia, according to a report in the December issue of Archives of Neurology, one of the JAMA/Archives journals.

"The concept of preclinical holds that the Alzheimer's pathologic process operates for many years before producing a clinically detectable impairment," the authors write as background information in the article. "A key corollary of this concept is that preclinical Alzheimer's disease is not benign and will eventually produce sufficient synaptic and neuronal damage to cause cognitive decline and other symptoms of Alzheimer's disease." Support for the existence of preclinical Alzheimer's disease comes from autopsies of cognitively normal older adults, many of whom have the brain plaques, tangles and deposits of a substance known as beta-amyloid that are characteristics of Alzheimer's disease.

Preclinical Alzheimer's disease can be detected by screening an individual's cerebrospinal fluid for biomarkers of the condition. In addition, imaging with positron emission tomography (PET) using a compound known as Pittsburgh Compound B (PiB), which binds to beta-amyloid, can detect deposits of the substance in living patients. John C. Morris, M.D., and colleagues at Washington University, St. Louis, assessed 159 older adults (average age 71.5) who had undergone PET scans using PiB and did not have symptoms of dementia. These patients were followed for between 0.8 and 5.5 years after having the scan and underwent between two and six assessments for dementia during that timeframe.

A total of 23 participants progressed to clinically detectable dementia during follow-up, and nine were diagnosed with dementia of the Alzheimer type. These diagnoses were made by specialist clinicians who diagnosed the condition at an earlier stage than typically occurs and corroborated the diagnosis by declines in multiple cognitive domains as well as a loss of volume in certain areas of the brain.

The PiB imaging identified individuals who would develop Alzheimer's disease-related dementia—those in whom the compound bound to more beta-amyloid plaques were more likely to develop this condition. However, it did not predict which individuals would develop not caused by Alzheimer's disease.

"Many more individuals, studied for longer intervals and ideally through autopsy, will be needed to confirm or refute our observations," the authors write. "Nonetheless, this study provides support for the premise that preclinical Alzheimer's disease, detected either by the cerebrospinal fluid signature for Alzheimer's disease or here by elevated PiB retention, predicts symptomatic Alzheimer's disease."

Explore further: Reducing kidney injury using a quality improvement method

More information: Arch Neurol. 2009;66[12]:1469-1475.

Provided by JAMA and Archives Journals

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Rapid weight loss may herald Alzheimer's

Sep 12, 2006

U.S. researchers say the slow, steady weight loss associated with aging may speed up prior to the onset of Alzheimer's disease and related dementias.

Recommended for you

Fatigue, fear are daily lot of Ebola fighters: experts

40 minutes ago

Doctors, nurses and hospital workers fighting the Ebola epidemic in west Africa are struggling with a daily burden of exhaustion, shortage of staff and fear for themselves over the deadly virus, specialists say.

Hong Kong makes Ebola 'contingency' measures

3 hours ago

Hong Kong said Wednesday it was quarantining all people from Guinea, Sierra Leone and Liberia who were showing Ebola-like symptoms on arrival in the city, as fears grow worldwide about the spread of the deadly virus.

EU ready for Ebola threat: sources

6 hours ago

The European Union is equipped and ready to treat victims should the deadly Ebola virus, which has killed hundreds in West Africa, be found in member states, EU sources said Wednesday.

Reducing kidney injury using a quality improvement method

11 hours ago

Using quality improvement measures in eight of the 10 hospitals in the Northern New England Cardiovascular Disease Study Group, researchers have found a way to reduce kidney injury in patients undergoing a procedure with ...

App for headache sufferers shows success

23 hours ago

A unique app that helps headache sufferers to record the severity and regularity of their pain is being used as part of a Griffith research study.

User comments : 0